245 related articles for article (PubMed ID: 31467178)
1. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
3. Benefit from the inclusion of radiation therapy in the treatment of patients with stage III classical Hodgkin lymphoma: A propensity matched analysis of the Surveillance, Epidemiology, and End Results database.
Bates JE; Dhakal S; Mazloom A; Casulo C; Constine LS
Radiother Oncol; 2017 Aug; 124(2):325-330. PubMed ID: 28778348
[TBL] [Abstract][Full Text] [Related]
4. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
Tao Y; Chen H; Liu D; Dai X
Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
[TBL] [Abstract][Full Text] [Related]
5. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis.
Gao J; Chen Y; Wu P; Wang F; Tao H; Shen Q; Wang S; Gong S; Zhang X; Zhou Z; Song X; Jia Y
BMC Cancer; 2021 Aug; 21(1):955. PubMed ID: 34433456
[TBL] [Abstract][Full Text] [Related]
6. Survival of Patients With Second Primary Hodgkin Lymphoma.
Budnik J; Doucette C; Milano MT; Constine LS
Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):316-323.e2. PubMed ID: 32014390
[TBL] [Abstract][Full Text] [Related]
7. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
Ali S; Olszewski AJ
Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
[TBL] [Abstract][Full Text] [Related]
8. Patterns of care and survival outcomes examining radiation therapy for advanced Hodgkin lymphoma.
Son CH; Chiu BC; Koshy M
Leuk Lymphoma; 2017 Feb; 58(2):343-347. PubMed ID: 27339611
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma at Groote Schuur Hospital, South Africa: the effect of HIV and bone marrow infiltration.
Swart L; Novitzky N; Mohamed Z; Opie J
Ann Hematol; 2019 Feb; 98(2):381-389. PubMed ID: 30397846
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.
Gunther JR; Fanale MA; Reddy JP; Akhtari M; Smith GL; Pinnix CC; Milgrom SA; Yehia ZA; Allen PK; Osborne EM; Mawlawi O; Dabaja BS
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):110-8. PubMed ID: 27325479
[TBL] [Abstract][Full Text] [Related]
11. The stage-specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score-matched analysis of the SEER database.
Wang S; Jia M; Han J; Zhang R; Huang K; Qiao Y; Chen P; Fu Z
Cancer Med; 2021 Jan; 10(2):540-551. PubMed ID: 33249743
[TBL] [Abstract][Full Text] [Related]
12. Primary therapy and relative survival in classical Hodgkin lymphoma: a nationwide population-based study in the Netherlands, 1989-2017.
Driessen J; Visser O; Zijlstra JM; Lugtenburg PJ; Plattel WJ; Kersten MJ; Dinmohamed AG
Leukemia; 2021 Feb; 35(2):494-505. PubMed ID: 32461630
[TBL] [Abstract][Full Text] [Related]
13. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
Skoetz N; Will A; Monsef I; Brillant C; Engert A; von Tresckow B
Cochrane Database Syst Rev; 2017 May; 5(5):CD007941. PubMed ID: 28541603
[TBL] [Abstract][Full Text] [Related]
14. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
Milano MT; Li H; Constine LS; Travis LB
Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Survival Rates of Patients with Stage III-IV Hodgkin Lymphoma According to Age, Sex, Race, and Socioeconomic Status, 1984-2013.
Li Y; Sun H; Yan Y; Sun T; Wang S; Ma H
Oncologist; 2018 Nov; 23(11):1328-1336. PubMed ID: 29739895
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy for patients with stage IV classical Hodgkin lymphoma: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wang S; Jia M; Han J; Zhang R; Huang K; Li P; Li Q; Qiao Y; Song Q; Fu Z
Cancer Biol Ther; 2020 Sep; 21(9):832-840. PubMed ID: 32835569
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases.
Han AY; Kuan EC; Alonso JE; Badran KW; St John MA
Otolaryngol Head Neck Surg; 2017 May; 156(5):870-876. PubMed ID: 28322119
[TBL] [Abstract][Full Text] [Related]
18. Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy.
Patel CG; Michaelson E; Chen YH; Silver B; Marcus KJ; Stevenson MA; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):498-506. PubMed ID: 29153331
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin Lymphoma Outcome: A Retrospective Study from 3 Tertiary Centers in Saudi Arabia.
Shafi RG; Al-Mansour MM; Kanfar SS; Al Hashmi H; Alsaeed A; Al-Foheidi M; Ibrahim EM
Oncol Res Treat; 2017; 40(5):288-292. PubMed ID: 28380488
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma.
Bates JE; Parikh RR; Mendenhall NP; Morris CG; Hoppe RT; Constine LS; Hoppe BS
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):522-529. PubMed ID: 32173399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
